NEUROPSYCHOMETRIC TESTS

Size: px
Start display at page:

Download "NEUROPSYCHOMETRIC TESTS"

Transcription

1 NEUROPSYCHOMETRIC TESTS

2 CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract thinking, perception and calculation

3 CAMCOG-2

4 CAMDEX It consists of three main sections: A structured clinical interview with the patient to obtain systematic information about the present condition, past history and family history; a range of objective cognitive tests which constitute a mini-neuropsychological battery; a structured interview with a relative or other informant to obtain independent information about the respondent's present state, past history and family history. Roth M et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia1986 Br J Psychiatry

5 CAMDEX-2 The CAMDEX test is acceptable to patients, has a high inter-rater reliability and the cognitive section has been shown to have high sensitivity and specificity.

6 Mini Mental State Examination (MMSE) It is brief 30- point questionnaire test that is used to screen for cognitive impairment (especially in MCI and AD patients)

7 Questions asked 'What is the date, day, month, year? 'Listen carefully. I am going to say three words. You say them back after I stop. Ready? Here they are APPLE [pause], PENNY [pause], TABLE [pause]. Now repeat those words back to me. 'What is this?' [Point to a pencil or pen.] 'Please read this and do what it says.' [Show examinee the following words on the stimulus form.] CLOSE YOUR EYES

8 MMSE-2 Orientation to time Orientation to place Registration Attention & Calculation Recall Language 5 points 5 points 3 points 5 points 3 points 9 points

9 Risk of Developing Alzheimer s Disease in Persons with MCI Survival curve of persons characterized as having a mild cognitive impairment for 6 years. Approximately 80% have converted to dementia during this time. Peterson RC, et al., Arch Neurol. 58: , 2001.

10 MMSE Specificity is good (96%) But the sensitivity is poor (63%) Using a standard cutoff score of 24 will leave a substantial proportion of cases of early dementia undetected. Asking patients and knowledgeable informants about deficits may enhance detection of early stages of AD abnormalities in learning and retaining new information difficulty handling complex tasks impaired reasoning ability changes in language or behavioral alterations

11 Available Screening Tests MMSE Too long min 7-Minute Screen 7 10 min Too complex Clock Drawing Test Not sensitive 2 4 min Mini-cog 3 5 min Complex scoring, unclear adequacy Memory Impairment Screen 4 min Need for slightly shorter, easier test (a suitably accurate test that takes less than 2 minutes is not available)

12 ALZHEIMER S DISEASE Estimate MMSE as a function of time MMSE score Estimated years into illness AAMI / MCI/ early AD -- DEMENTIA Ashford et al., 1995

13 Global Deterioration Scale-1 Stage 1 Stage 2 Stage 3 Stage 4 Normal; no memory complaints and no evident cognitive impairment. Very mild; memory problem reported, but not evident in clinical interview. Mild impairment in memory, concentration, and occupational performance. Moderate impairment in memory, knowledge retrieval, and complex tasks.

14 ADAS-Cog (Alzheimer Disease Assessment Scale- Cognitive) It consists of 11 tasks measuring the disturbances of memory, language, praxis, attention and other cognitive abilities which are known as the core symptoms of AD It is used in multicentric studies focused on studying the intensity of main symptoms of dementia as well as assessing the effect of the treatment. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry Nov;141(11):

15 ADAS-Cog-2

16 Global Deterioration Scale-2 Stage 5 Moderate to severe impairment in both recent and remote memory, frequent disorientation to time and place, and impairment in ADLs that indicates need for caregiver assistance. Stage 6 Severe impairment with inability to tend to ADLs without assistance. Stage 7 Very severe impairment in cognition, language, and motor skills, progressing to a less functional, vegetative state.

17 Hamilton rating scale (HDRS) 21-question multiple choice questionnaire that the clinicians may use to rate the severity of a patient s major depression The questionnaire rates the severity of symptoms observed in depression such as low mood, insomnia, agitation, anxiety and weight loss Hamilton, M (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry

18 Functional cognitive assessment scale (FUCAS) It is a new reliable cognitive- behavioral scale that assesses executive function in daily life activities directly in patients with dementia. FUCAS can discriminate patients with MCI from those with moderate-severe dementia Kounti et al., 2006

19 FRSSD (Functional Rating Scale for Symptoms of Dementia) It tests executive function

20 Trail making test (A,B) Neuropsychological test of visual attention and task switching. The task requires a subject to connect the dots' of 25 consecutive targets on a sheet of paper or computer screen. Reitan R. M. (1958). Validity of the Trail Making test as an indicator of organic brain damage. Percept. Mot Skills, 8,

21 Trail making test (A,B) Two versions are available: A, in which the targets are all numbers (1,2,3, etc.), and B, in which the subject alternates between numbers and letters (1, A, 2, B, etc.).

22 Steps of exam performance Step 1: Give the patient a copy of the Trail Making Test Part A worksheet and a pen or pencil. Step 2: Demonstrate the test to the patient using the sample sheet (Trail Making Part A SAMPLE). Step 3: Time the patient as he or she follows the trail made by the numbers on the test. Step 4: Record the time. Step 5: Repeat the procedure for Trail Making Test Part B

23 Tests

24 Scoring Results for both TMT A and B are reported as the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Trail A: Average 29 seconds, deficiency>78 seconds Trail B: Average 75 seconds, deficiency>273 seconds

25 Clinical dementia rating It is used to quantify the severity of symptoms in dementia The six domains tested were : Memory, Orientation, Judgment and Problem-solving, Community Affairs, Home and Hobbies, and Personal Care. necessary information to make each rating is obtained through a semi-structured interview of the patient and a reliable informant or collateral source (e.g., family member). Morris JC. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993; 43:

26 Scoring

27 Clock drawing test-1 A test that can be used as a part of a neurological test or as a assessment tool for Alzheimer's disease and other types of dementia. It is brief and easy to administer The person undergoing testing is asked to; Draw a clock Put in all the numbers Set the hands at ten past eleven.

28 Clock drawing test-2 It may detect deficits in executive functioning that are overlooked by other routine cognitive tests, such as the Mini Mental Status Examination (MMSE).

29 Behave-AD It is a scale for measuring behavioral and psychiatric symptoms in patients with Alzheimer's disease

30 Behave-AD-2 It can measure agitation/anxiety (agitation, anxiety of upcoming events; other anxiety), psychosis (delusions of theft, suspiciousness/paranoia; visual hallucinations), aggression (verbal aggressiveness; physical threats/violence; fear of being left alone; other delusions), depression (tearfulness; depressed mood) and activity disturbance (wandering; delusion one's house is not one's home

31 Neuropsychiatric inventory (NPI) It is used to assess 10 behavioral disturbances occurring in dementia patients such as delusions, hallucinations, dysphoria, anxiety, agitation/aggression, euphoria, disinhibition, irritability/lability, apathy, and aberrant motor activity It examines and scores only those behavioral domains with positive responses to screening questions. Cummings J et al., Neurology 1994

32 Questionnaire (Is it all Greek or Chinese to you?)

33 Apathy assessment

34 MOCA (Montreal Cognitive Assessment) It is a cognitive screening test designed to assist Health Professionals for detection of mild cognitive impairment Nasreddine ZS, et al. The Montreal Cognitive Assessment (MoCA): A Brief Screening Tool For Mild Cognitive Impairment. J Am Geriatr Soc 53: , 2005.

35 MOCA (Montreal Cognitive Assessment)-2

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE 5.1 GENERAL BACKGROUND Neuropsychological assessment plays a crucial role in the assessment of cognitive decline in older age. In India, there

More information

Alzheimer s disease dementia: a neuropsychological approach

Alzheimer s disease dementia: a neuropsychological approach Alzheimer s disease dementia: a neuropsychological approach Dr. Roberta Biundo, PhD Neuropsychology Coordinator at Parkinson s disease and movement disorders unit of San Camillo rehabilitation hospital

More information

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why? Neuropsychological assessment of older adults: what, when and why? Benjamin Mast, Ph.D. Associate Professor & Vice Chair, Psychological & Brain Sciences Associate Clinical Professor, Family & Geriatric

More information

Physical & Functional Assessments in Older Adults

Physical & Functional Assessments in Older Adults Physical & Functional Assessments in Older Adults Scott Martin Vouri, PharmD, MSCI, BCPS, CGP, FASCP St. Louis College of Pharmacy Faculty Disclosure Dr. Vouri is funded by the Washington University Institute

More information

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients Blackwell Science, LtdOxford, UKPCNPsychiatry and Clinical Neurosciences1323-13162005 Blackwell Publishing Pty Ltd593274279Original ArticleDementia and mild AlzheimersJ. Shimabukuro et al. Psychiatry and

More information

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Measure Description Percentage of patients with dementia for whom there was a documented screening* for behavioral

More information

Capacity and Older Adults. Kenneth I. Shulman

Capacity and Older Adults. Kenneth I. Shulman Capacity and Older Adults Kenneth I. Shulman Increased Requests for Contemporaneous Assessments of Testamentary Capacity Increase in challenges to testamentary capacity Demographics/Economics Prevalence

More information

THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME

THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME PERNECZKY 15/06/06 14:35 Page 1 THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME R. PERNECZKY, A. KURZ Department of Psychiatry and Psychotherapy, Technical University of Munich, Germany. Correspondence

More information

AGED SPECIFIC ASSESSMENT TOOLS. Anna Ciotta Senior Clinical Neuropsychologist Peninsula Mental Health Services

AGED SPECIFIC ASSESSMENT TOOLS. Anna Ciotta Senior Clinical Neuropsychologist Peninsula Mental Health Services AGED SPECIFIC ASSESSMENT TOOLS Anna Ciotta Senior Clinical Neuropsychologist Peninsula Mental Health Services Issues in assessing the Elderly Association between biological, psychological, social and cultural

More information

The Neuropsychiatric Inventory Questionnaire: Background and Administration

The Neuropsychiatric Inventory Questionnaire: Background and Administration The Neuropsychiatric Inventory Questionnaire: Background and Administration The Neuropsychiatric Inventory Questionnaire (NPI-Q) was developed and crossvalidated with the standard NPI to provide a brief

More information

Identification of Cognitive Impairment in HIV patients. Belinda Vicioso MD FACP, AGSF Jose Garcia Professor of Medicine UTSW

Identification of Cognitive Impairment in HIV patients. Belinda Vicioso MD FACP, AGSF Jose Garcia Professor of Medicine UTSW Identification of Cognitive Impairment in HIV patients Belinda Vicioso MD FACP, AGSF Jose Garcia Professor of Medicine UTSW New emphasis on cognition Why? Common in our patient population Often overlooked

More information

Assessment of People with Early Dementia and their Families

Assessment of People with Early Dementia and their Families Assessment of People with Early Dementia and their Families Claudia K Y Lai, RN, PhD Professor, School of Nursing The Hong Kong Polytechnic University Advanced Management of People with Early Dementia

More information

Neuropsychiatric Inventory Nursing Home Version (NPI-NH)

Neuropsychiatric Inventory Nursing Home Version (NPI-NH) This is a Sample version of the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) The full version of the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) comes without sample watermark..

More information

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia 86 Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia Pai-Yi Chiu 1,3, Chung-Hsiang Liu 2, and Chon-Haw Tsai 2 Abstract- Background: Neuropsychiatric profile

More information

Neuropsychological Evaluation of

Neuropsychological Evaluation of Neuropsychological Evaluation of Alzheimer s Disease Joanne M. Hamilton, Ph.D. Shiley-Marcos Alzheimer s Disease Research Center Department of Neurosciences University of California, San Diego Establish

More information

Table 2B: Summary of Select Screening and Initial Assessment Tools for Vascular Cognitive Impairment in Stroke Patients (Updated 2014)

Table 2B: Summary of Select Screening and Initial Assessment Tools for Vascular Cognitive Impairment in Stroke Patients (Updated 2014) Table 2B: Summary of Select Screening and Initial s for Vascular Cognitive Impairment in Stroke Patients (Updated 2014) Recommended First Line Screening and s Montreal Cognitive (MoCA) The MoCA is available

More information

UDS Progress Report. -Standardization and Training Meeting 11/18/05, Chicago. -Data Managers Meeting 1/20/06, Chicago

UDS Progress Report. -Standardization and Training Meeting 11/18/05, Chicago. -Data Managers Meeting 1/20/06, Chicago UDS Progress Report -Standardization and Training Meeting 11/18/05, Chicago -Data Managers Meeting 1/20/06, Chicago -Training material available: Gold standard UDS informant and participant interviews

More information

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease What is PRESENTS DEMENTIA? WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: Memory Reasoning Planning Learning Attention Language Perception Behavior AS OF 2013 There

More information

Cognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.

Cognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University. Cognitive Screening in Risk Assessment Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University Outline of Talk Definition of Dementia and MCI Incidence and Prevalence

More information

Number of Items. Response Categories. Part V: Specific Behavior Scales-Sleep Scales. Based on past month

Number of Items. Response Categories. Part V: Specific Behavior Scales-Sleep Scales. Based on past month Part V: Specific Behavior Scales-Sleep Scales Based on past month First 4 items ask for time or amount of sleep 41. Pittsburgh Sleep Quality Index (PSQI) Sleep quality Sleep latency Sleep duration Habitual

More information

David A Scott Lis Evered. Department of Anaesthesia and Acute Pain Medicine St Vincent s Hospital, Melbourne University of Melbourne

David A Scott Lis Evered. Department of Anaesthesia and Acute Pain Medicine St Vincent s Hospital, Melbourne University of Melbourne David A Scott Lis Evered Department of Anaesthesia and Acute Pain Medicine St Vincent s Hospital, Melbourne University of Melbourne This talk will include live polling so please be sure to have the meeting

More information

Montreal Cognitive Assessment (MoCA) Overview for Best Practice in Stroke and Complex Neurological Conditions March 2013

Montreal Cognitive Assessment (MoCA) Overview for Best Practice in Stroke and Complex Neurological Conditions March 2013 Montreal Cognitive Assessment (MoCA) Overview for Best Practice in Stroke and Complex Neurological Conditions March 2013 1 MoCA 2 Overview of the MoCA Takes approximately 15 minutes to administer Requires

More information

Neuropsychiatric Syndromes

Neuropsychiatric Syndromes Neuropsychiatric Syndromes Susan Czapiewski,MD VAHCS December 10, 2015 Dr. Czapiewski has indicated no potential conflict of interest to this presentation. She does intend to discuss the off-label use

More information

The Rest is Noise. The Promise of ecoa in Increasing Signal Detection

The Rest is Noise. The Promise of ecoa in Increasing Signal Detection Medavante Research White paper The Rest is Noise The Promise of ecoa in Increasing Signal Detection By Christopher Randolph, PhD, ABPP-CN Medical Director of Neuropsychology, Loyola University Medical

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #283: Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

Table 7.2B: Summary of Select Screening Tools for Assessment of Vascular Cognitive Impairment in Stroke Patients

Table 7.2B: Summary of Select Screening Tools for Assessment of Vascular Cognitive Impairment in Stroke Patients Table 7.2B: Summary of Select Screening Tools for Assessment of Vascular Cognitive Impairment in Stroke Patients Recommended First Line Screening and s Montreal Cognitive (MoCA) The MoCA is available for

More information

CRITICALLY APPRAISED PAPER (CAP)

CRITICALLY APPRAISED PAPER (CAP) CRITICALLY APPRAISED PAPER (CAP) FOCUSED QUESTION Is an individualized occupational therapy program more effective in modulating mood disturbances and functional deficits than general skills training for

More information

The place for treatments of associated neuropsychiatric and other symptoms

The place for treatments of associated neuropsychiatric and other symptoms The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public

More information

Behavioral Interventions

Behavioral Interventions Behavioral Interventions Linda K. Shumaker, R.N.-BC, MA Pennsylvania Behavioral Health and Aging Coalition Behavioral Management is the key in taking care of anyone with a Dementia! Mental Health Issues

More information

City, University of London Institutional Repository

City, University of London Institutional Repository City Research Online City, University of London Institutional Repository Citation: Hurt, C. S., Banerjee, S., Tunnard, C., Whitehead, D. L., Tsolaki, M., Mecocci, P., Kloszewska, I., Soininen, H., Vellas,

More information

Measuring health-related quality of life in persons with dementia DOMS results & recommendations

Measuring health-related quality of life in persons with dementia DOMS results & recommendations Measuring health-related quality of life in persons with dementia DOMS results & recommendations Madeleine King, Siggi Zapart, Jan Sansoni, Nick Marosszeky On behalf of the Dementia Outcomes Measurement

More information

Test Assessment Description Ref. Global Deterioration Rating Scale Dementia severity Rating scale of dementia stages (2) (4) delayed recognition

Test Assessment Description Ref. Global Deterioration Rating Scale Dementia severity Rating scale of dementia stages (2) (4) delayed recognition Table S. Cognitive tests used in the Georgia Centenarian Study. Test Assessment Description Ref. Mini-Mental State Examination Global cognitive performance A brief screening of orientation, memory, executive

More information

ORIGINAL ARTICLE Neuroscience INTRODUCTION MATERIALS AND METHODS

ORIGINAL ARTICLE Neuroscience INTRODUCTION MATERIALS AND METHODS ORIGINAL ARTICLE Neuroscience DOI: 10.46/jkms.2010.25.7.1071 J Korean Med Sci 2010; 25: 1071-1076 Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring

More information

QUESTIONNAIRE: Finland

QUESTIONNAIRE: Finland QUESTIONNAIRE: Finland To put the assessment and management of behavioural disorders into a broader context of social and health policy and services in Finland, some background information is presented.

More information

Psychiatric Morbidity in Dementia Patients in a Neurology-Based Memory Clinic

Psychiatric Morbidity in Dementia Patients in a Neurology-Based Memory Clinic Original Articles 179 Psychiatric Morbidity in Dementia Patients in a Neurology-Based Memory Clinic Ching-Sen Shih 1, Sui-Hing Yan 2, Ying-Hoo Ho 1, Yuh-Te Lin 1, Jie-Yuan Li 1, and Yuk-Keung Lo 1 Abstract-

More information

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT RUTH KOHEN ASSOCIATE PROFESSOR UW DEPARTMENT OF PSYCHIATRY 5-4-2017

More information

Parkinsonian Disorders with Dementia

Parkinsonian Disorders with Dementia Parkinsonian Disorders with Dementia George Tadros Consultant in Old Age Liaison Psychiatry, RAID, Heartlands Hospital Professor of Dementia and Liaison Psychiatry, Aston Medical School Aston University

More information

Burden of behavioral and psychiatric symptoms in people screened positive for dementia in primary care results of the DelpHi-study René Thyrian

Burden of behavioral and psychiatric symptoms in people screened positive for dementia in primary care results of the DelpHi-study René Thyrian Burden of behavioral and psychiatric symptoms in people screened positive for dementia in primary care results of the DelpHi-study René Thyrian German Center for Neurodegenerative Diseases (DZNE), site

More information

UDS version 3 Summary of major changes to UDS form packets

UDS version 3 Summary of major changes to UDS form packets UDS version 3 Summary of major changes to UDS form packets from version 2 to VERSION 3 february 18 final Form A1: Subject demographics Updated question on principal referral source to add additional options

More information

Assessing and Managing the Patient with Cognitive Decline

Assessing and Managing the Patient with Cognitive Decline Assessing and Managing the Patient with Cognitive Decline Center of Excellence For Alzheimer s Disease for State of NY Capital Region Alzheimer s Center of Albany Medical Center Earl A. Zimmerman, MD Professor

More information

Erin Cullnan Research Assistant, University of Illinois at Chicago

Erin Cullnan Research Assistant, University of Illinois at Chicago Dr. Moises Gaviria Distinguished Professor of Psychiatry, University of Illinois at Chicago Director of Consultation Liaison Service, Advocate Christ Medical Center Director of the Older Adult Program,

More information

Management of the Acutely Agitated Long Term Care Patient

Management of the Acutely Agitated Long Term Care Patient Management of the Acutely Agitated Long Term Care Patient 80 60 Graying of the Population US Population Over Age 65 Millions of Persons 40 20 0 1900 1920 1940 1960 1980 1990 2010 2030 Year Defining Dementia

More information

Baseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston

Baseline Characteristics of Patients Attending the   Memory Clinic Serving the South Shore of Boston Article ID: ISSN 2046-1690 Baseline Characteristics of Patients Attending the www.thealzcenter.org Memory Clinic Serving the South Shore of Boston Corresponding Author: Dr. Anil K Nair, Chief of Neurology,

More information

Hollis Day, MD, MS Chief, Geriatrics BMC

Hollis Day, MD, MS Chief, Geriatrics BMC Hollis Day, MD, MS Chief, Geriatrics BMC Mari-Lynn Drainoni, PhD Associate Professor, Department of Health Law Policy and Management, BUSPH Co-Director, Evans Center for Implementation and Improvement

More information

Korean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP)

Korean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP) Korean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP) Yeonwook Kang, Ph.D. Department of Psychology, Hallym University Department of Neurology, Hallym University Sacred Heart

More information

PREVALENCE AND CORRELATES OF ANXIETY IN ALZHEIMER S DISEASE

PREVALENCE AND CORRELATES OF ANXIETY IN ALZHEIMER S DISEASE 166 Chemerinski et al. DEPRESSION AND ANXIETY 7:166 170 (1998) PREVALENCE AND CORRELATES OF ANXIETY IN ALZHEIMER S DISEASE Erán Chemerinski, M.D., 1 * Gustavo Petracca, M.D., 1 Facundo Manes, M.D., 2 Ramón

More information

Recognizing Dementia can be Tricky

Recognizing Dementia can be Tricky Dementia Abstract Recognizing Dementia can be Tricky Dementia is characterized by multiple cognitive impairments that cause significant functional decline. Based on this brief definition, the initial expectation

More information

Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer s disease and their caregivers

Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer s disease and their caregivers International Psychogeriatrics (2008), 20:2, 383 393 C 2007 International Psychogeriatric Association doi:10.1017/s1041610207006254 Printed in the United Kingdom Reliability of the Brazilian Portuguese

More information

Assessing cognitive function after stroke. Glyn Humphreys

Assessing cognitive function after stroke. Glyn Humphreys Assessing cognitive function after stroke Glyn Humphreys (glyn.humphreys@psy.ox.ac.uk) Write down 3 important cognitive problems after stroke What things are important to detect? OCS Impairment incidences

More information

The Quick Dementia Rating System (QDRS): A rapid dementia staging tool

The Quick Dementia Rating System (QDRS): A rapid dementia staging tool Alzheimer s & Dementia: Diagnosis, Assessment & Disease Monitoring 1 (2015) 249-259 The Quick Dementia Rating System (QDRS): A rapid dementia staging tool James E. Galvin* Departments of Neurology, Psychiatry,

More information

WHOS complex needs clients data survey: assessment and treatment options

WHOS complex needs clients data survey: assessment and treatment options 2 WHOS complex needs clients data survey: assessment and treatment options Assessment options: peer-reviewed and grey literature; policy, procedure and practice (PPP) 1: People With Exceptionally Complex

More information

Information Gathering Obtaining history is the most critical first step Patient-provided history may not be reliable Need info from relatives, friends

Information Gathering Obtaining history is the most critical first step Patient-provided history may not be reliable Need info from relatives, friends ASSESSING COMPETENCE Michael A Hill MD UNC Psychiatry 2008 Information Gathering Obtaining history is the most critical first step Patient-provided history may not be reliable Need info from relatives,

More information

Cognitive Assessment 4/29/2015. Learning Objectives To be able to:

Cognitive Assessment 4/29/2015. Learning Objectives To be able to: Supporting the Desire to Age in Place: Important Considerations for the Aging Population AGENDA 8:45 9:00 AM Geriatric Principles Robert L. Kane, MD *9:00 9:55 AM Cognitive Assessments Ed Ratner, MD 10:00

More information

Caregiving for an Individual with Dementia: Beginning the Journey

Caregiving for an Individual with Dementia: Beginning the Journey Caregiving for an Individual with Dementia: Beginning the Journey Kirsten W. Schwehm, PhD, ABN Institute for Dementia Research and Prevention Getting the Diagnosis Physician Assessment Cognitive Assessment

More information

Dementia and Alzheimer s disease

Dementia and Alzheimer s disease Since 1960 Medicine Korat โรงพยาบาลมหาราชนครราชส มา Dementia and Alzheimer s disease Concise Reviews PAWUT MEKAWICHAI MD DEPARTMENT of MEDICINE MAHARAT NAKHON RATCHASIMA HOSPITAL 1 Prevalence Increase

More information

THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL

THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL DID YOU KNOW THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL. Did you know that it is essential to know the target cluster(s)/symptom(s) one is treating to guide and monitor non-pharmacological approaches and pharmacological

More information

Introduction to the diagnosis of dementia

Introduction to the diagnosis of dementia Introduction to the diagnosis of dementia Serge Gauthier and Pedro Rosa-Neto This chapter will outline general strategies to establish the presence and the differential diagnosis of dementia, and the case

More information

3/6/2019 DIAGNOSIS OF DEMENTIA IN THE OUTPATIENT SETTING FINANCIAL DISCLOSURES LEARNING OBJECTIVES

3/6/2019 DIAGNOSIS OF DEMENTIA IN THE OUTPATIENT SETTING FINANCIAL DISCLOSURES LEARNING OBJECTIVES DIAGNOSIS OF DEMENTIA IN THE OUTPATIENT SETTING MILTA LITTLE, DO, CMD DUKE UNIVERSITY SCHOOL OF MEDICINE FINANCIAL DISCLOSURES Dr. Little has no relevant financial disclosures to report Dr. Little will

More information

CRITICALLY APPRAISED PAPER (CAP)

CRITICALLY APPRAISED PAPER (CAP) CRITICALLY APPRAISED PAPER (CAP) Godefroy, O., Fickl, A., Roussel, M., Auribault, C., Bugnicourt, J. M., Lamy, C., Petitnicolas, G. (2011). Is the Montreal cognitive assessment superior to the mini-mental

More information

Moca test instructions

Moca test instructions Moca test instructions The Borg System is 100 % Moca test instructions Voici une information que j emprunte (eh oui, c est aussi à cela que sert le web) au site Neuropsychologie.fr (section Blog). Le MoCA

More information

Measuring health related quality of life in persons with dementia

Measuring health related quality of life in persons with dementia University of Wollongong Research Online Australian Health Services Research Institute Faculty of Business 2008 Measuring health related quality of life in persons with dementia Madeleine King University

More information

Case Presentation. Cognition: changes with Normal Aging? Synonyms

Case Presentation. Cognition: changes with Normal Aging? Synonyms Case Presentation 78 yr old new patient presenting for new PCP after discharge from hospital stay Discharged 3 days ago Summary : admitted with new atrial fibrillation, with history of DM, CHF. In hospital,

More information

Range of neuropsychiatric disturbances in patients with Parkinson s disease

Range of neuropsychiatric disturbances in patients with Parkinson s disease 492 Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital D Aarsland N G Lim C Janvin Department of Neurology, Central Hospital of Rogaland, Stavanger, Norway J P Larsen K Karlsen E Tandberg Departments

More information

FACTORS AFFECTING CAPACITY

FACTORS AFFECTING CAPACITY FACTORS AFFECTING CAPACITY Psychosocial Factors Affecting Capacity Psychosocial factors include one s surroundings, way of life & things that affect relationships between the adult and their environment.

More information

Cognitive Assessment. Part Two: Assessing Capacity, Beyond The Basics. Using Information To Make Decisions (Appreciating) What s s The Correct Method?

Cognitive Assessment. Part Two: Assessing Capacity, Beyond The Basics. Using Information To Make Decisions (Appreciating) What s s The Correct Method? AUTONOMY, CAPACITY AND UNDUE INFLUENCE: KEMP Page 1 of 9 Part Two: Assessing Capacity, Beyond The Basics Cognitive Assessment Bryan Kemp, Ph. D. Center of Excellence in Elder Abuse and Neglect UC Irvine

More information

WHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide April 2014

WHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide April 2014 WHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide April 2014 1. Introduction This release consists of a single data set from the WHIMS Epidemiology of Cognitive Health Outcomes

More information

MINI MENTAL STATE EXAM

MINI MENTAL STATE EXAM MINI MENTAL STATE EXAM ID NUMBER: FORM CODE: M M E DATE: 06/01/2011 Version 2.0 ADMINISTRATIVE INFORMATION 0a. Completion Date: / / 0b. Staff ID: Month Day Year Materials: Black pen, pencil, wrist watch,

More information

Implementation of a Dementia Screening Tool (Poster)

Implementation of a Dementia Screening Tool (Poster) Lehigh Valley Health Network LVHN Scholarly Works Patient Care Services / Nursing Implementation of a Dementia Screening Tool (Poster) Amanda Fougere Lehigh Valley Health Network, Amanda_A.Fougere@lvhn.org

More information

Understanding the Progression of Alzheimer s and Related Dementias And Planning for Future Changes

Understanding the Progression of Alzheimer s and Related Dementias And Planning for Future Changes Town Hall Forum Making a Plan: The Smart Approach to Alzheimer s Care Needs May 25, 2017 Understanding the Progression of Alzheimer s and Related Dementias And Planning for Future Changes Daniel D. Sewell,

More information

02/04/2015. The structure of the talk. Dementia as a motor disorder. Movement, cognition & behaviour. Example 1. Example 2

02/04/2015. The structure of the talk. Dementia as a motor disorder. Movement, cognition & behaviour. Example 1. Example 2 The th Annual Memory Clinic Conference Dublin, Trinity College, 27 March 1 The structure of the talk Dementia as a motor disorder Thomas H. Bak Human Cognitive Neuroscience & Centre for Clinical Brain

More information

Quality ID #291: Parkinson s Disease: Cognitive Impairment or Dysfunction Assessment National Quality Strategy Domain: Effective Clinical Care

Quality ID #291: Parkinson s Disease: Cognitive Impairment or Dysfunction Assessment National Quality Strategy Domain: Effective Clinical Care Quality ID #291: Parkinson s Disease: Cognitive Impairment or Dysfunction Assessment National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Medicare Part C Medical Coverage Policy

Medicare Part C Medical Coverage Policy Medicare Part C Medical Coverage Policy Neuropsychological Testing Origination: September 19, 2001 Review Date: February 21, 2018 Next Review: February, 2020 DESCRIPTION OF PROCEDURE SERVICE Neuropsychological

More information

Empire BlueCross BlueShield Professional Commercial Reimbursement Policy

Empire BlueCross BlueShield Professional Commercial Reimbursement Policy Subject: Documentation Guidelines for Central Nervous System Assessments and Tests NY Policy: 0046 Effective: 12/01/2014 11/30/2015 Coverage is subject to the terms, conditions, and limitations of an individual

More information

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER OVERCOMING THE CHALLENGES OF MANAGING CHRONIC DISEASES IN PERSONS WITH DEMENTIA DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER LEARNING OBJECTIVES Be familiar with the diagnostic criteria for

More information

Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials

Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials Alzheimer s & Dementia 4 (2008) 390 394 Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials Donald J. Connor a, *, Marwan N. Sabbagh a, Jeffery L. Cummings b a Cleo

More information

Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT

Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms State of the art lecture March 4-2012 Philippe H Robert, Philippe Nice - France Robert The diagnosis of AD Neuropsychiatric

More information

Recent findings: Dementia Outcomes Measurement Suite

Recent findings: Dementia Outcomes Measurement Suite University of Wollongong Research Online Australian Health Services Research Institute Faculty of Business 008 Recent findings: Dementia Outcomes Measurement Suite Janet Sansoni University of Wollongong,

More information

CLINICAL DEMENTIA RATING SUMMARY

CLINICAL DEMENTIA RATING SUMMARY CLINICAL DEMENTIA RATING SUMMARY ID NUMBER: FORM CODE: C D S DATE: 4//6 Version. ADMINISTRATIVE INFORMATION a. Completion Date: / / b. Staff ID: Month Day Year Instructions: This form is to be completed

More information

Screening for Cognitive Impairment

Screening for Cognitive Impairment Screening for Cognitive Impairment Screening for Cognitive Impairment. Educational Consultant Pearson April 27, 2017 Presentation Title Arial Bold 7 pt 1 Agenda What is Cognitive Impairment? Implications

More information

Ageing in Place: A Multi-Sensor System for Home- Based Enablement of People with Dementia

Ageing in Place: A Multi-Sensor System for Home- Based Enablement of People with Dementia Ageing in Place: A Multi-Sensor System for Home- Based Enablement of People with Dementia Dr Louise Hopper, Rachael Joyce, Dr Eamonn Newman, Prof. Alan Smeaton, & Dr. Kate Irving Dublin City University

More information

Comparison of clock drawing with Mini Mental State Examination as a screening test in elderly acute hospital admissions

Comparison of clock drawing with Mini Mental State Examination as a screening test in elderly acute hospital admissions Postgrad Med J (1993) 69, 696-700 A) The Fellowship of Postgraduate Medicine, 199: Comparison of clock drawing with Mini Mental State Examination as a screening test in elderly acute hospital admissions

More information

Driving and Dementia Practical Tips for the Family Physician

Driving and Dementia Practical Tips for the Family Physician Driving and Dementia Practical Tips for the Family Physician L. Lee, MD, MClSc, CCFP, FCFP 2015 Canadian Medical Association. Determining fitness to operate motor vehicles: CMA Driver s Guide, 7th ed.

More information

Driving and Dementia Practical Tips for the Family Physician. L. Lee, MD, MClSc, CCFP, FCFP 2014

Driving and Dementia Practical Tips for the Family Physician. L. Lee, MD, MClSc, CCFP, FCFP 2014 Driving and Dementia Practical Tips for the Family Physician L. Lee, MD, MClSc, CCFP, FCFP 2014 Medico-legal problems related to fitness to drive CMPA experience, 2005-2009: 67 medico-legal cases Half

More information

Objectives. My Patient: The story 10/6/2017

Objectives. My Patient: The story 10/6/2017 Objectives Our Grey Matter Matters: A Case in Point Vivien Brown MDCM, CCFP,FCFP, NCMP Assistant Professor, University of Toronto Vice President, Medical Affairs, Medisys Healthy Group Past President,

More information

Dementia. Assessing Brain Damage. Mental Status Examination

Dementia. Assessing Brain Damage. Mental Status Examination Dementia Assessing Brain Damage Mental status examination Information about current behavior and thought including orientation to reality, memory, and ability to follow instructions Neuropsychological

More information

Mining for Lost Memories: A Best Practice Approach for Alzheimer s Disease Diagnosis

Mining for Lost Memories: A Best Practice Approach for Alzheimer s Disease Diagnosis Mining for Lost Memories: A Best Practice Approach for Alzheimer s Disease Diagnosis Michael Rosenbloom, MD and Terry Barclay, PhD HealthPartners Center for Dementia and Alzheimer s Care Presentation Outline

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a preprint version which may differ from the publisher's version. For additional information about this

More information

DEMENTIA MEASURES GROUP OVERVIEW

DEMENTIA MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: DEMENTIA MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN DEMENTIA MEASURES GROUP: #280. Dementia: Staging of Dementia #281. Dementia: Cognitive Assessment #282. Dementia:

More information

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences

More information

2013 AAIC WW-ADNI Meeting, Boston K-ADNI Update

2013 AAIC WW-ADNI Meeting, Boston K-ADNI Update 2013 AAIC WW-ADNI Meeting, Boston K-ADNI Update July 12th, 2013 Seong Yoon Kim, Seol Hee Han, Duk L. Na Update for K-ADNI, 2013 General Year1 Tasks Infrastructure setup for K-ADNI is under way. Database

More information

KINGSTON DEMENTIA RATING SCALE

KINGSTON DEMENTIA RATING SCALE KINGSTON DEMENTIA RATING SCALE -KDRS- I-RatingForm II - Instruction Manual III - Score Interpretation IV - Chart Summary Copyright 2015 R.W. Hopkins, L. Kilik Semoprs Mental Health, Providence Care, Mental

More information

Neuropsychiatric Inventory - Nursing Home Version (NPI-NH)

Neuropsychiatric Inventory - Nursing Home Version (NPI-NH) Neuropsychiatric Inventory - Nursing Home Version (NPI-NH) Comprehensive Assessment of Psychopathology in Patients with Dementia Residing in Nursing Homes NPI - NH Neuropsychiatric Inventory Nursing Home

More information

SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS

SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS Dr Paraskevi Sakka Neurologist - Psychiatrist Athens Association of Alzheimer s Disease and Related Disorders Neurodegenerative

More information

Geriatric Grand Rounds

Geriatric Grand Rounds Geriatric Grand Rounds Screening for Dementia in a Multicultural Context Zahinoor Ismail BMSc MD FRCPC Tuesday, June 15, 2010 12:00 noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping

More information

ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health

ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health ALZHEIMER S DISEASE OVERVIEW Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health Prevalence AD: DEMOGRAPHY AND CLINICAL FEATURES Risk and protective factors Clinical features and

More information

Management of Behavioral Problems in Dementia

Management of Behavioral Problems in Dementia Management of Behavioral Problems in Dementia Ghulam M. Surti, MD Clinical Assistant Professor Department of Psychiatry and Human Behavior Warren Alpert Medical School of Brown University Definition of

More information

Nature, prevalence and clinical significance. Barcelona, Spain

Nature, prevalence and clinical significance. Barcelona, Spain Nature, prevalence and clinical significance Jaime Kulisevsky Barcelona, Spain 1 Non motor (neuropsychiatric) symptoms are an integral part of Parkinson s s disease (PD) Affective disorders And are associated

More information

Dr. W. Dalziel Professor, Geriatric Medicine Ottawa Hospital. November /20/ Safety: Falls/Cooking/Unsafe Behaviour. 2.

Dr. W. Dalziel Professor, Geriatric Medicine Ottawa Hospital. November /20/ Safety: Falls/Cooking/Unsafe Behaviour. 2. How To Decide if an Elderly Person Can Stay at Home: The Interval of Need Concept Dr. W. Dalziel Professor, Geriatric Medicine Ottawa Hospital November 2013 3 Factors 1. Safety: Falls/Cooking/Unsafe Behaviour

More information

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration Annual Scientific Meeting Canadian Geriatric Society Philippe Desmarais,

More information